Activated charcoal

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Chronic Kidney DiseaseMultiple SclerosisTrialTED

172 competitors in Chronic Kidney Disease

#DrugCompanyPhaseTrials

1

Activated charcoal

Sanofi

Phase 3

22

Uloric

Takeda

Preclinical

23

Sovaldi

Gilead

Preclinical

14

Glucotrol

Pfizer

Preclinical

15

Vemlidy

Gilead

Preclinical

16

Lorelco

Sanofi

Preclinical

17

Activase

Roche

Preclinical

—8

Flomax

Sanofi

Preclinical

—9

Verquvo

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

110

PROCRIT

WWim Janssens

Preclinical

1Show 36 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

TED2 trials

Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous

Unknown status·—·Phase 2·NCT04311645·90 enrolled

Phenytoin and Multidose Activated Charcoal

Completed·EEmory University·N/A·NCT00823264·17 enrolled

Chronic Kidney Disease2 trials

Activated Charcoal Use in Chronic Kidney Disease Patients

Recruiting·MMansoura University·Phase 2·NCT06906874·40 enrolled

Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease

Unknown status·WWaleed Khaild Rahman Kareem Al-kabi·Phase 2/3·NCT05540431·60 enrolled

Absorption1 trial

A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects

Completed·Eli Lilly·Phase 1·NCT01389752·22 enrolled

Tolerance1 trial

Does a Soft Drink Mixture Improve Tolerance of Activated Charcoal in the Adult Poisoned Patient Without Affecting Efficacy

Completed·SState University of New York - Upstate Medical University·Phase 4·NCT06219967·5 enrolled

Single Dose1 trial

A Study on The Effect of Multiple Doses of Activated Charcoal on The Pharmacokinetics of a Single Dose of RO4995819

Completed·Roche·Phase 1·NCT01409369·26 enrolled

8 more indications

Pruritus1 trial

The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus.

Not yet recruiting·—·Phase 2·NCT06579066·123 enrolled

Tics1 trial

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects

Completed·GSK·Phase 1·NCT02691325·22 enrolled

Lung Cancer1 trial

Charcoal in Lung Cancer Patients Undergoing TEMLA

Withdrawn·MMasonic Cancer Center, University of Minnesota·Phase 2·NCT04928950

Invasive Procedure1 trial

Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants

Withdrawn·UUniversity Hospital, Angers·Phase 4·NCT02969746

Trial1 trial

Activated CHARcoal in Poisoned Patient - Pilot Trial

Recruiting·LLaval University·Phase 4·NCT05471479·100 enrolled

Rivaroxaban1 trial

Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.

Completed·—·Phase 1·NCT04767776·12 enrolled

Osmolality Disturbance1 trial

Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay

Active, not recruiting·SState University of New York - Upstate Medical University··NCT07220031·8 enrolled

Multiple Sclerosis1 trial

Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis

Active, not recruiting·Sanofi·Phase 3·NCT06141473·1,655 enrolled

Details

Drug Info

Related News